BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs7903146, FOXP1, Angiogenesis, Allergy to pollen, Liver, Anticancer prodrugs)
Bookmark Forward

QuickView for NSD2 (gene)


Body Atlas

Most Correlated Tissues

  1. Granulocyte-macrophage progenitor cell of bone marrow
  2. Bone marrow
  3. Dendritic (plasmacytoid) cell
  4. Testes
  5. Thymus gland
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Abscess
  2. Microbial culture finding
  3. Osteomyelitis
  4. Whipple's disease
  5. Edema
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Glycocholic Acid
  2. Trichlorfon
  3. Biperiden
  4. Ambroxol
  5. Cisapride
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ERVK3-1
  2. TSHR
  3. DUSP5
  4. CASP10
  5. HIC1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Intestinal NSD2 Aggravates Nonalcoholic Steatohepatitis Through Histone Modifications.
  2. NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptos…
  3. Multilevel Regulation of NF-κB Signaling by NSD2 Suppresses Kras-Driven Pancreatic Tumorigenesis.
  4. Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions t…
  5. ISWI chromatin remodeling complexes recruit NSD2 and H3K36me2 in pericentromeric heterochromatin.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
  2. A Study of the Safety, Tolerability and Effectiveness of EZM0414 Investigative Product in Participan…
  3. Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma
  4. Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell Lymphoma
  5. A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Thera…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.